Dividend Announcement for Pfizer Limited Shareholders
Indian investors holding shares in Pfizer Limited have received positive news. The pharmaceutical giant has announced a dividend of ₹165 per share for the fiscal year 2024-25. This represents a significant return for investors, particularly considering the current market conditions.
Details of the Dividend Payment
Pfizer Limited will distribute a total of ₹165 per share, comprised of a final dividend of ₹35 per share and a special dividend of ₹130 per share. This payment will be made to each equity share with a face value of ₹10.
Record Date and Share Purchase Deadline
The company has set the record date for dividend distribution at July 9th. To be eligible for this dividend, investors must have purchased Pfizer shares by July 8th. Shares purchased on or after the record date will not receive the dividend payment.
Company’s Current Status in the Share Market
As of 11:15 AM on June 25th, Pfizer Limited shares were trading at ₹5579.00, up by ₹20.70 on the BSE. The intraday low for the day was ₹5562.10, while the intraday high reached ₹5634.90. Over the past year, the shares have delivered a b return to investors, ranging from a low of ₹3742.90 to a high of ₹6452.85.
The company’s current market capitalization stands at ₹25,595.86 crore, reflecting its b and established position within the pharmaceutical sector.
Introduction to Pfizer Limited
Pfizer Limited is a subsidiary of the American pharmaceutical company, Pfizer Inc. Based in India, the company is involved in the manufacturing, distribution, and marketing of pharmaceutical products. Pfizer is recognized for its contributions in life-saving medications, vaccines, and therapy-based products.
With decades of operation in India, Pfizer has built a b brand reputation. The company’s strategy has consistently focused on producing high-quality medicines and delivering consistent returns to investors.
Implications for Investors
The dividend of ₹165 per share represents a substantial return for investors. For instance, an investor holding 100 shares would receive a total dividend of ₹16,500. While this income is fully taxable, it demonstrates the company’s robust financial standing. The dividend yield is approximately 3% based on the current market price, which is competitive with many other pharmaceutical companies.
Should You Invest?
For investors seeking long-term investments in stable and reputable companies, Pfizer Limited presents a promising option. The company’s business model, international connections, and consistent dividend payouts make it a reliable investment choice. However, it’s crucial to conduct thorough research, including analyzing the company’s financial statements, future growth projections, and the overall industry landscape, before making any investment decisions. While the dividend is a positive indicator, investors should also consider potential price fluctuations and market conditions.
